相似文献
1
Understanding Fatigue in Sjögren's Syndrome: Outcome Measures, Biomarkers and Possible Interventions.
Front Immunol. 2021 Jun 25;12:703079. doi: 10.3389/fimmu.2021.703079. eCollection 2021.
2
Targeting primary Sjögren's syndrome.
Mod Rheumatol. 2019 Jan;29(1):70-86. doi: 10.1080/14397595.2018.1546268.
3
Fatigue in Sjögren's Syndrome: A Search for Biomarkers and Treatment Targets.
Front Immunol. 2019 Feb 26;10:312. doi: 10.3389/fimmu.2019.00312. eCollection 2019.
4
Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.
Int J Mol Sci. 2018 Oct 30;19(11):3392. doi: 10.3390/ijms19113392.
5
Differential cytokine expression and regulatory cells in patients with primary and secondary Sjögren's syndrome.
Scand J Immunol. 2014 Dec;80(6):432-40. doi: 10.1111/sji.12224.
6
Serum dehydroepiandrosterone sulphate levels and laboratory and clinical parameters indicating expression of disease are not associated with fatigue, well-being and functioning in patients with primary Sjögren's syndrome.
Clin Exp Rheumatol. 2011 Mar-Apr;29(2):318-21. Epub 2011 Apr 19.
7
Fatty infiltration of the minor salivary glands is a selective feature of aging but not Sjögren's syndrome.
Autoimmunity. 2017 Dec;50(8):451-457. doi: 10.1080/08916934.2017.1385776. Epub 2017 Oct 8.
8
The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue and Immune Responses in Patients With Primary Sjögren's Syndrome.
Neuromodulation. 2019 Jul;22(5):580-585. doi: 10.1111/ner.12879. Epub 2018 Oct 17.
9
Ophthalmologic Manifestations of Primary Sjögren's Syndrome.
Genes (Basel). 2021 Mar 4;12(3):365. doi: 10.3390/genes12030365.
10
Outcome measures for primary Sjögren's syndrome: a comprehensive review.
J Autoimmun. 2014 Jun;51:51-6. doi: 10.1016/j.jaut.2013.12.010. Epub 2014 Jan 8.
引用本文的文献
1
FatiguE in Sjögren's Syndrome: a randomised controlled trial of cOmbined Non-phArmacological therapeutic strategies (FESSONA).
BMJ Open Sport Exerc Med. 2025 Jun 16;11(2):e002677. doi: 10.1136/bmjsem-2025-002677. eCollection 2025.
2
Cross-cultural adaptation and validation of the Chinese version of the PSS-QoL questionnaire.
PLoS One. 2024 Dec 5;19(12):e0313839. doi: 10.1371/journal.pone.0313839. eCollection 2024.
3
Improved Fatigue Management in Primary Sjögren's Syndrome: A Retrospective Analysis of the Efficacy of Methotrexate in Chinese Patients.
J Inflamm Res. 2024 Oct 21;17:7551-7560. doi: 10.2147/JIR.S475605. eCollection 2024.
4
Update on the pathophysiology and treatment of primary Sjögren syndrome.
Nat Rev Rheumatol. 2024 Aug;20(8):473-491. doi: 10.1038/s41584-024-01135-3. Epub 2024 Jul 9.
5
Emerging biologic frontiers for Sjogren's syndrome: Unveiling novel approaches with emphasis on extra glandular pathology.
Front Pharmacol. 2024 May 17;15:1377055. doi: 10.3389/fphar.2024.1377055. eCollection 2024.
6
Oral health status, related behaviours and perceived stress in xerostomia, Sicca and Sjögren's syndromes patients - a cross-sectional study.
BMC Oral Health. 2024 Apr 15;24(1):454. doi: 10.1186/s12903-024-04224-7.
7
The Physical and Psychosocial Impact of Fatigue among Patients with Sjogren's Syndrome: A Systematic Review.
J Clin Med. 2024 Mar 7;13(6):1537. doi: 10.3390/jcm13061537.
8
Fatigue and sleep quality in Chinese adults with connective tissue disease: A cross-sectional study.
Sleep Breath. 2024 Jun;28(3):1449-1457. doi: 10.1007/s11325-024-02993-7. Epub 2024 Jan 24.
9
Development and validation of a nomogram for predicting fatigue in patients with primary Sjögren's syndrome.
Clin Rheumatol. 2024 Feb;43(2):717-724. doi: 10.1007/s10067-023-06853-9. Epub 2023 Dec 28.
10
NMDA Receptors in Health and Diseases: New Roles and Signaling Pathways-Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Autoantibodies as Potential Biomarkers of Fatigue in Patients with Rheumatic Diseases.
Int J Mol Sci. 2023 Feb 10;24(4):3560. doi: 10.3390/ijms24043560.
本文引用的文献
1
Pain and fatigue are predictors of quality of life in primary Sjögren's syndrome.
Adv Rheumatol. 2021 May 29;61(1):28. doi: 10.1186/s42358-021-00181-9.
2
The Role of Interferons in the Pathogenesis of Sjögren's Syndrome and Future Therapeutic Perspectives.
Biomolecules. 2021 Feb 9;11(2):251. doi: 10.3390/biom11020251.
3
Transcranial direct current stimulation for fatigue in patients with Sjogren's syndrome: A randomized, double-blind pilot study.
Brain Stimul. 2021 Jan-Feb;14(1):141-151. doi: 10.1016/j.brs.2020.12.004. Epub 2020 Dec 17.
4
Acinar adipose tissue infiltration in salivary gland biopsy is associated with kynurenines-Interferon-γ pathway inflammation biomarkers.
Clin Exp Rheumatol. 2020 Jul-Aug;38 Suppl 126(4):27-33. Epub 2020 Oct 22.
5
Improvement of Severe Fatigue Following Nuclease Therapy in Patients With Primary Sjögren's Syndrome: A Randomized Clinical Trial.
Arthritis Rheumatol. 2021 Jan;73(1):143-150. doi: 10.1002/art.41489. Epub 2020 Nov 22.
6
An Innovative Online Qualitative Study to Explore the Symptom Experience of Patients with Primary Sjögren's Syndrome.
Rheumatol Ther. 2020 Sep;7(3):601-615. doi: 10.1007/s40744-020-00220-9. Epub 2020 Jul 28.
7
Correlation of sleep quality with fatigue and disease activity among patients with primary Sjögren's syndrome: a cross-sectional study.
Sao Paulo Med J. 2020 Mar;138(2):146-151. doi: 10.1590/1516-3180.2019.0251.R1.1912019. Epub 2020 Mar 9.
8
Fatigue in primary Sjögren's syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study.
Rheumatol Int. 2019 Nov;39(11):1867-1873. doi: 10.1007/s00296-019-04354-0. Epub 2019 Jun 27.
9
Effectiveness of resistance exercise in functional fitness in women with primary Sjögren's syndrome: randomized clinical trial.
Scand J Rheumatol. 2020 Jan;49(1):47-56. doi: 10.1080/03009742.2019.1602880. Epub 2019 Jun 27.
10
Prognostic markers of lymphoma development in primary Sjögren syndrome.
Lupus. 2019 Jul;28(8):923-936. doi: 10.1177/0961203319857132. Epub 2019 Jun 19.
Zotero 插件